Hsu Jason — SEC Form 4 filings
SEC reporting owner CIK 1895035. 7 Form 4 filings on record with FilingPulse; latest filed 2026-05-29.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-05-20 to 2026-05-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 3 filings — 80,000 shares, $175,498 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: purchase of 40,000 shares @ $2.19 ($87,680) in Immix Biopharma, Inc., filed 2024-12-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | Director | 7 | 6 legs · 80,000 sh · $175,498 | — | 6 |
Form 4 filings — Hsu Jason
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-29 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | Immix Biopharma, Inc. (IMMX) | Purchase (P): 7,700 @ $2.17 · Purchase (P): 40,000 @ $2.19 | EDGAR |
| 2024-08-26 | 4 | Immix Biopharma, Inc. (IMMX) | Purchase (P): 15,000 @ $2.23 · Purchase (P): 8,100 @ $2.25 | EDGAR |
| 2024-07-31 | 4 | Immix Biopharma, Inc. (IMMX) | Purchase (P): 3,200 @ $2.07 · Purchase (P): 6,000 @ $2.15 | EDGAR |
| 2024-06-21 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 21,587 (derivative) @ $0 · Grant/award (A): 25,512 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1895035 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →